A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)

Cristina Gasparetto; Suzanne Lentzsch; Gary J. Schiller; William Bensinger; Nizar J. Bahlis; Heather J. Sutherland; Darrell White; Michaël Sébag; Rami Kotb; Christopher P. Venner

doi:10.1182/blood.v130.suppl_1.3100.3100

A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)

Identifier:nobleid.org/w1/20260515/0505EB9F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0505EB9F.svg?ark=w1%2F20260515%2F0505EB9F)](https://nobleid.org/work/w1/20260515/0505EB9F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Heather J. Sutherland

Darrell White

Michaël Sébag

Rami Kotb

Christopher P. Venner

Claim authorship of this work

A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)

Identifier:nobleid.org/w1/20260515/0505EB9F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0505EB9F.svg?ark=w1%2F20260515%2F0505EB9F)](https://nobleid.org/work/w1/20260515/0505EB9F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Heather J. Sutherland

Darrell White

Michaël Sébag

Rami Kotb

Christopher P. Venner

Claim authorship of this work